Literature DB >> 17395211

Effect of anti-dementia drugs on LPS induced neuroinflammation in mice.

Ethika Tyagi1, Rahul Agrawal, Chandishwar Nath, Rakesh Shukla.   

Abstract

Inflammation has been recently implicated in pathogenesis of dementia disorders. Effect of anti-dementia (Acetylcholinesterase inhibitor) drugs tacrine, rivastigmine and donepezil were studied on neuroinflammation induced by intraperitoneal administration of lipopolysaccharide (LPS) in mice. Interleukin-2 (IL-2) and isoforms of acetylcholinesterase (AChE) were estimated in different brain areas as marker for neuroinflammation and cholinergic activity respectively. LPS significantly increased the level of IL-2 in all the brain areas while enhancement of AChE activity varied in brain areas. It was found that administration of tacrine, rivastigmine and donepezil in mice significantly attenuated the LPS induced increased levels of IL-2 along with the significant reduction of AChE activity predominantly in salt soluble (SS) fraction as compared to the detergent soluble (DS) fraction in a dose dependent manner. In vitro effect of LPS was also studied in different brain areas. LPS significantly increased the AChE activity in SS fractions but the significant increase was not found in DS fractions. The present study indicate that cholinesterase inhibitor anti-dementia drugs are effective against LPS induced neuroinflammation that may be linked to enhanced cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395211     DOI: 10.1016/j.lfs.2007.02.039

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  LPS and neuroinflammation: a matter of timing.

Authors:  Patricia C Lopes
Journal:  Inflammopharmacology       Date:  2016-09-19       Impact factor: 4.473

2.  Redefining the role of peripheral LPS as a neuroinflammatory agent and evaluating the role of hydrogen sulphide through metformin intervention.

Authors:  Virendra Tiwari; Manjari Singh; Jitendra K Rawat; Uma Devi; Rajnish K Yadav; Subhadeep Roy; Swetlana Gautam; Shubhini A Saraf; Vikas Kumar; Nazam Ansari; Abdulaziz S Saeedan; Gaurav Kaithwas
Journal:  Inflammopharmacology       Date:  2016-08-03       Impact factor: 4.473

3.  Chronological changes in inflammatory cytokines immunoreactivities in the mouse hippocampus after systemic administration of high dosage of tetanus toxin.

Authors:  Bing Chun Yan; Joon Ha Park; In Hye Kim; Bich Na Shin; Ji Hyeon Ahn; Ki-Yeon Yoo; Deuk-Sik Lee; Myong Jo Kim; Il-Jun Kang; Moo-Ho Won
Journal:  Exp Brain Res       Date:  2012-09-19       Impact factor: 1.972

Review 4.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

5.  Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease.

Authors:  Amy Easton; Sethu Sankaranarayanan; An Tanghe; Dick Terwel; Alan X Lin; Nina Hoque; Clotilde Bourin; Huidong Gu; Michael Ahlijanian; Linda Bristow
Journal:  Psychopharmacology (Berl)       Date:  2013-06-20       Impact factor: 4.530

6.  Autonomic and cholinergic mechanisms mediating cardiovascular and temperature effects of donepezil in conscious mice.

Authors:  Aaron J Polichnowski; Geoffrey A Williamson; Tesha E Blair; Donald B Hoover
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-14       Impact factor: 3.210

Review 7.  Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential.

Authors:  Saikat Mitra; Maniza Muni; Nusrat Jahan Shawon; Rajib Das; Talha Bin Emran; Rohit Sharma; Deepak Chandran; Fahadul Islam; Md Jamal Hossain; Sher Zaman Safi; Sherouk Hussein Sweilam
Journal:  Oxid Med Cell Longev       Date:  2022-08-18       Impact factor: 7.310

Review 8.  Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use.

Authors:  Anna Skrzypczak-Wiercioch; Kinga Sałat
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.